Personal care major Colgate-Palmolive has developed an antiperspirant formula containing cannabidiol (CBD) that it says works as an anti-irritant on the skin. Writing in its international patent, Colgate-Palmolive said it had developed the antiperspirant in response to a growing need for gentler, anti-irritant antiperspirants and to align with the surging interest in CBD. The formulation had been designed for use in various antiperspirant deodorant forms, including roll-on, stick, gel and even aerosol.
Colgate-Palmolive said whilst there was a wealth of “conventional antiperspirant salts” used by industry, including aluminium and zirconium salts, many could cause skin irritation. And with an estimated 50% of the world population considered to have sensitive skin, it said there was a clear need for an alternative. “It is therefore desirable to develop and formulate efficacious anti-irritant ingredients into personal care products to mitigate potential irritant-induced redness, tingling, itching, or burning of the skin to a tolerable level for improved consumer compliance,” Colgate Palmolive wrote in its patent filing.
By Kacey Culliney – 10 Jun 2021
Exclusive webinar in English 👉 Click here to watch the replay Discover the latest evaluation…
Georgina Caldwell 28 February 2025 THE WHAT? Shiseido’s patented, proprietary optical clearing technique, which makes skin…
The global beauty industry is undergoing a transformative shift as consumers increasingly prioritize transparency, sustainability,…